kzollove
commented
8 months ago These concepts were destandardized but not mapped (only including one concept when name repeated many times):
<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns="http://www.w3.org/TR/REC-html40">
concept_id | concept_name -- | -- 35939580 | Clinically abnormal peripheral lymph node(s), histopathologically confirmed \|BUT Dutch grade and NCI LN grade unknown:\| Clone positive, negative or unknown 35940179 | Clinically abnormal peripheral lymph nodes \|AND histopathologically Dutch grades 3-4 or NCI LN 4:\| Clone positive or negative or unknown\|\|Stated as N3 with no other information on regional lymph nodes 35931796 | Clinically abnormal peripheral lymph nodes\|- Pathologically Dutch grades 3-4 or NCI LN 4 \|- Clone positive or negative or unknown\|\|Central nodes\|- Pathologically Dutch grades 3-4 or NCI LN 4\|- Clone positive, negative, or unknown 35922355 | Clinically normal peripheral lymph node(s), histopathologically confirmed \|BUT Dutch grade and NCI LN grade unknown:\| Clone positive, negative or unknown 35936724 | Clinically normal peripheral lymph nodes \|AND histopathologically Dutch grades 3-4 or NCI LN 4:\| Clone positive or negative or unknown 35941810 | Four-Grade System 35917160 | Fuhrman Nuclear Grade 35918328 | Grade 35917557 | Grade - Melanoma Origin 35918542 | Grade Clinical 35918437 | Grade Path System 35918842 | Grade Path Value 35918640 | Grade Pathological 35918519 | Grade Post Therapy 35928475 | Grade X\|Unknown or no information\|Not documented in patient record 35919954 | Grade cannot be assessed (GX); Unknown ... 35927738 | Grade cannot be assessed (GX); Unknown \|Not a follicular histology (9690/3, 9691/3, 9695/3, 9698/3) ... 35921264 | Grade cannot be assessed (GX); Unknown \|Not applicable ... 35914128 | Grade cannot be assessed; Unknown ... 35917462 | Grade for Sarcomas ... 35919765 | Grade/differentiation unknown, not stated, or not applicable 35939852 | In situ, intraepithelial, noninvasive \|Intraductal tumor\|Biliary intraepithelial neoplasia grade 3 (BiIIN-3) 35933533 | In situ, intraepithelial, noninvasive, preinvasive\|Cancer in situ WITH endocervical gland involvement\|\|Cervical intraepithelial neoplasia (CIN) Grade III 35937667 | In situ, intraepithelial, noninvasive; high grade dysplasia 35926128 | In situ, intraepithelial, noninvasive\|High-grade biliary intraepithelial neoplasia (BilIn-3) 35938036 | In situ, intraepithelial, noninvasive\|High-grade biliary intraepithelial neoplasia (BilIn-3) 35934826 | In situ: Noninvasive; intraepithelial\|- High-grade pancreatic intraepithelial neoplasia (PanIn-3)\|- Intraductal papillary mucinous neoplasm with high grade dysplasia\|- Intraductal tubulopapillary neoplasm with high grade dysplasia\|- Mucinous cystic neopl 35929500 | In situ: noninfiltrating; intraepithelial\|Intraductal WITHOUT infiltration\|Lobular neoplasia, grade 3 (LIN 3) 35930554 | Limited to one fallopian tube AND\|- No tumor on fallopian tube surface AND\|- No malignant cells in ascites or peritoneal washings \|\|High-grade serous tubal intraepithelial carcinoma (STIC)\|\|FIGO Stage IA 35935721 | Limited to one ovary (capsule intact) AND\|- No tumor on ovarian surface AND\|- No malignant cells in ascites or peritoneal washings\|- WITH or WITHOUT high-grade serous tubal intraepithelial carcinoma (STIC)\|\|FIGO Stage IA 35921196 | Limited to penis\|- WITH perineural and/or lymphovascular invasion\|- WITH or WITHOUT high grade (i.e., grade 3 or sarcomatoid) 35923524 | Limited to penis\|- WITHOUT perineural and/or lymphovascular invasion\|- WITH low grade (i.e., grade 1-2) or UNKNOWN grade 35917950 | Mucoepidermoid Carcinoma - Grade 35922383 | Neither BR grade nor BR score given\|Unknown or no information\|Not documented in patient record 35917681 | Nottingham or Bloom-Richardson (BR) Score/Grade 35917685 | OBSOLETE - WHO Grade Classification 35917927 | OBSOLETE - WHO Grade Classification 35940308 | Three-Grade System 35917728 | Tumor Regression Grade 35918077 | Tumor Regression Grade 35940518 | Two-Grade System 35917178 | WHO/ISUP Grade ... 35917726 | World Health Organization (WHO) Grade Classification ... 35921405 | GB: Borderline Tumor ... 35920824 | G3B: > 15 centroblasts per HPF and solid sheets of centroblasts ... 35919509 | Medulloblastoma, SHH-activated and TP53-wildtype (9471/3) 35920443 | TP53 or CTNNB Mutation ... 35937813 | G3A: >15 centroblasts per HPF and centrocytes present ...
Destandardize and map to Cancer Modifier:
grade_NAACCR.csv